↓ Skip to main content

Cochrane Database of Systematic Reviews

Single dose oral nefopam for acute postoperative pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, July 2009
Altmetric Badge

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
67 Mendeley
Title
Single dose oral nefopam for acute postoperative pain in adults
Published in
Cochrane database of systematic reviews, July 2009
DOI 10.1002/14651858.cd007442.pub2
Pubmed ID
Authors

Manish Kakkar, Sheena Derry, R Andrew Moore, Henry J McQuay

Abstract

Nefopam is a centrally-acting but non-opioid analgesic drug of the benzoxazocine chemical class, developed in the early 1970s. It is widely used, mainly in European countries, for the relief of moderate to severe pain as an alternative to opioid analgesic drugs, and used in rheumatic disease and other musculoskeletal disorders in the UK. This review sought to evaluate the efficacy and safety of oral nefopam in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties.

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 13%
Researcher 8 12%
Student > Bachelor 5 7%
Other 4 6%
Student > Doctoral Student 3 4%
Other 9 13%
Unknown 29 43%
Readers by discipline Count As %
Medicine and Dentistry 18 27%
Nursing and Health Professions 8 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Psychology 3 4%
Biochemistry, Genetics and Molecular Biology 1 1%
Other 4 6%
Unknown 30 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2023.
All research outputs
#13,725,838
of 23,983,331 outputs
Outputs from Cochrane database of systematic reviews
#10,354
of 12,820 outputs
Outputs of similar age
#92,881
of 113,322 outputs
Outputs of similar age from Cochrane database of systematic reviews
#60
of 74 outputs
Altmetric has tracked 23,983,331 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,820 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.8. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 113,322 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.